Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Breathtec Biomedical Inc (OTC: BTHCF).

Full DD Report for BTHCF

You must become a subscriber to view this report.


Recent News from (OTC: BTHCF)

Breathtec Biomedical Announces Appointment of CEO
VANCOUVER, British Columbia, March 01, 2018 (GLOBE NEWSWIRE) -- Breathtec Biomedical Inc. (CSE:BTH) (CNSX:BTH) (FRANKFURT:BTI) (OTCQB:BTHCF) (the “Company”) is pleased to announce the appointment of Christopher J. Moreau as Chief Executive Officer effective March 1, ...
Source: GlobeNewswire
Date: March, 01 2018 09:00
UPDATE -- Breathtec Biomedical Provides Development Update on Breathalyzer for Disease Detection
VANCOUVER, British Columbia, Jan. 25, 2018 (GLOBE NEWSWIRE) -- Please note this is an Official Company News Release. Breathtec Biomedical Inc. (CSE:BTH) (CNSX:BTH) (FRANKFURT:BTI) (OTCQB:BTHCF) (the “Company”) is pleased to report on the development of it...
Source: GlobeNewswire
Date: January, 25 2018 09:27
Breathtec Biomedical Provides Development Update on Breathalyzer for Disease Detection
VANCOUVER, British Columbia, Jan. 25, 2018 (GLOBE NEWSWIRE) -- The Following Is an Investment Opinion Being Issued by the Audience Marketing Inc. Breathtec Biomedical Inc. (CSE:BTH) (CNSX:BTH) (FRANKFURT:BTI) (OTCQB:BTHCF) (the “Company”) is pleased to report ...
Source: GlobeNewswire
Date: January, 25 2018 09:00
Horizons Marijuana Life Sciences Index ETF Is A Best Bet For The Passive Marijuana Investor
Note: This article contains both Canadian- and U.S.-traded ticker symbols. Caution should be exercised with these gray-market derivatives. The Horizons Marijuana Life Sciences Index ETF (HMLSF) has performed well, and there is no reason to expect otherwise as 2018 progresses. I ...
Source: SeekingAlpha
Date: January, 03 2018 11:10
Upcoming Seasonal Anomalies: A Marijuana Stock Focus
It was really a pleasure to read Ted's recent Seeking Alpha article and participate in the comments, where a few were interested in my thoughts on the U.S. side of tax loss selling. That is what motivated me to write this article. I hope you find it interesting. Tax Loss Selling to Match ...
Source: SeekingAlpha
Date: November, 21 2017 07:28
Breathtec Biomedical Unaware of Any Material Change
VANCOUVER, BC--(Marketwired - Nov 14, 2017) - Breathtec Biomedical, Inc. ( CSE : BTH ) ( OTCQB : BTHCF ) (the " Company " or " Breathtec ") - at the request of the Investment Industry Regulatory Organization of Canada, Breathtec has confirmed that its management is unaware of any material ...
Source: Marketwired
Date: November, 14 2017 13:49
Breathtec Biomedical Announces Resignation of Chief Executive Officer
VANCOUVER, BC--(Marketwired - Sep 20, 2017) -  Breathtec Biomedical Inc. ( CSE : BTH ) ( CNSX : BTH ) ( FRANKFURT : BTI ) ( OTCQB : BTHCF ) (the "Company") announces that effective immediately, Guy La Torre has resigned as Director and Chief Executive Officer ("CEO") of the Comp...
Source: Marketwired
Date: September, 20 2017 17:05
Breathtec BioMedical to Investigate Zika Virus Airborne Disease Detection
VANCOUVER, BC--(Marketwired - May 18, 2017) - Breathtec BioMedical, Inc . ( CSE : BTH ) ( CNSX : BTH ) ( FRANKFURT : BTI ) ( OTCQB : BTHCF ) (the " Company " or " Breathtec "), a medical diagnostics company focused on developing, in-licensing and commercializing proprietary, innovative ...
Source: Marketwired
Date: May, 18 2017 09:00
Breathtec BioMedical CTO Delivers Presentation to International Science Community
VANCOUVER, BC--(Marketwired - Mar 17, 2017) - Breathtec BioMedical, Inc . ( CSE : BTH.CN ) ( CNSX : BTH ) ( CSE : BTH ) ( FRANKFURT : BTI ) ( OTCQB : BTHCF ) (the " Company " or " Breathtec "), a medical diagnostics company focused on developing, in-licensing and commercializing propri...
Source: Marketwired
Date: March, 17 2017 09:00
Breathtec Biomedical Provides Corporate Overview
VANCOUVER, BC--(Marketwired - Mar 1, 2017) - Breathtec BioMedical, Inc . (CSE: BTH.CN) ( CNSX : BTH ) ( CSE : BTH ) ( FRANKFURT : BTI ) ( OTCQB : BTHCF ) (the " Company " or " Breathtec "), a medical diagnostics company focused on developing, in-licensing and commercializing proprietary...
Source: Marketwired
Date: March, 01 2017 08:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-08-170.09560.0930.1050.09365,410
2018-08-160.10360.100.10360.095660,550
2018-08-150.100.100.1050.1041,250
2018-08-140.096320.1050.1050.09372,755
2018-08-130.102230.100710.1050.0935128,594

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-171,00065,4101.5288Cover
2018-08-1625,50060,55042.1140Short
2018-08-1522,25051,25043.4146Short
2018-08-1443,80072,75560.2020Short
2018-08-1330,994128,59424.1022Cover

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on BTHCF.


About Breathtec Biomedical Inc (OTC: BTHCF)

Logo for Breathtec Biomedical Inc (OTC: BTHCF)

The company aims to advance breath analysis technology for the early screening of life threatening diseases.

 

 

 

Current Management

  • Michael Sadhra / CFO
  • Raj Attariwala /
  • David Levine /

Current Share Structure

  • Market Cap: $11,109,290 - 03/09/2018
  • Authorized: 100,000,000 - 03/24/2017
  • Issue and Outstanding: 55,518,691 - 01/24/2018
  • Float: 50,485,839 - 03/24/2017

 


Recent Filings from (OTC: BTHCF)

Management Discussion and Analysis - Management Discussion and Analysis
Filing Type: Management Discussion and Analysis - Management Discussion and AnalysisFiling Source: OTC Markets
Filing Date: January, 25 2018
Quarterly Report - Quarterly Report
Filing Type: Quarterly Report - Quarterly ReportFiling Source: OTC Markets
Filing Date: January, 25 2018
Management Discussion and Analysis - Management Discussion and Analysis
Filing Type: Management Discussion and Analysis - Management Discussion and AnalysisFiling Source: OTC Markets
Filing Date: December, 21 2017
Annual Report - Annual Report
Filing Type: Annual Report - Annual ReportFiling Source: OTC Markets
Filing Date: December, 21 2017
Management Discussion and Analysis - Management Discussion and Analysis
Filing Type: Management Discussion and Analysis - Management Discussion and AnalysisFiling Source: OTC Markets
Filing Date: July, 24 2017
Quarterly Report - Quarterly Report
Filing Type: Quarterly Report - Quarterly ReportFiling Source: OTC Markets
Filing Date: July, 24 2017
Management Discussion and Analysis - Management Discussion and Analysis
Filing Type: Management Discussion and Analysis - Management Discussion and AnalysisFiling Source: OTC Markets
Filing Date: April, 28 2017
Quarterly Report - Quarterly Report
Filing Type: Quarterly Report - Quarterly ReportFiling Source: OTC Markets
Filing Date: April, 28 2017
OTCQB Certification - Certification
Filing Type: OTCQB Certification - CertificationFiling Source: OTC Markets
Filing Date: March, 24 2017
Annual Report - Annual Report
Filing Type: Annual Report - Annual ReportFiling Source: OTC Markets
Filing Date: January, 31 2017

 

 


Daily Technical Chart for (OTC: BTHCF)

Daily Technical Chart for (OTC: BTHCF)


Stay tuned for daily updates and more on (OTC: BTHCF)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: BTHCF)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in BTHCF is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of BTHCF and does not buy, sell, or trade any shares of BTHCF. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/